What is the role of ECP in steroid refractory patients with GVHD? And what is the evidence confirming acceptable response rates and safety of ECP in these patient populations?

What is the role of ECP in steroid refractory patients with GVHD? And what is the evidence confirming acceptable response rates and safety of ECP in these patient populations?

What is the role of ECP in steroid refractory patients with GVHD? And what is the evidence confirming acceptable response rates and safety of ECP in these patient populations?


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Daniel Couriel, MD, MS

Daniel Couriel, MD, MS

Daniel R. Couriel, MD, MS
Professor of Internal Medicine
Director, Huntsman Cancer Institute (HCI) Blood and Marrow Transplant Program
University of Utah School of Medicine
Salt Lake City, UT